Deleterious network: A testable pathogenetic concept of alzheimer’s disease

Gerontology

Volumn 43, Issue 4, 1997, Pages 242-253

  Ying, Weihai ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer s disease; Amyloid precursor protein metabolism; Calcium homeostasis; Energy metabolism; Oxidative damage; Pathogenesis

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CALCIUM ION;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CALCIUM HOMEOSTASIS; ENERGY METABOLISM; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; OXIDATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; CALCIUM; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; MODELS, THEORETICAL; OXIDATION-REDUCTION; OXIDATIVE STRESS; RISK FACTORS;

EID: 0030835921     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000213856     Document Type: Article

References (99)

1. Fraliglioni L: Epidemiology of Alzheimer’s disease and current possibilities for prevention. Acta Neurol Scand 1996:165(suppl):33-40.
2. Lippa CF, Saunders AM, Smith TW, Swearer JM, Drachman DA, Ghetti B, Nee L, Pulaski-Salo D, Dickson D, Robitaille Y, Bergeron C, Crain B, Benson MD, Farlow M, Hyman BT, St Gcorge-Hyslop P, Roses AD, Pollen DA: Familial and sporadic Alzheimer's disease: Neuropathology cannot exclude a final common pathway. Neurology 1996; 46:406-412.
3. Ying W: Deleterious network hypothesis of Alzheimer’s disease. Med Hypotheses 1996;46:421-428.
4. Hardy JA, Higgins GA: Alzheimer’s disease: The amyloid cascade hypothesis. Science 1992:256:184-185.
5. Behl C, Davis JB, Lesley R, Schubert D: Hydrogen peroxide mediates amyloid ß protein toxicity. Cell 1994:77:817-827.
6. Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, Floyd RA, Butterfield DA: A model for ß-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease. Proc Natl Acad Sei USA 1994:91:3270-3274.
7. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Mörser J, Migheli A, Nawroth P, Stem D, Schmidt AM: RAGE and amvloid-ß peptide neurotoxicity in Alzheimer’s disease. Nature 1996:382:685-691.
8. Mattson MP, Goodman Y: Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium. Brain Res 1995:676: 219-224.
9. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M: ß-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 1996: 380:168-171.
10. Kaneko I, Yamada N, Sakuraba Y, Kamenosono M, Tutumi S: Suppression of mitochondrial succinate dehydrogenase, a primary target of ß-amyloid, and its derivative raccm-ized at Ser residue. J Neurochem 1995:65:2585-2593.
11. Mattson MP, Tomasclli KJ, Rydcl RE: Calcium-destabilizing and neu-rodegenerative effects of aggregated ß-amyloid peptide are attenuated by basic FGF. Brain Res 1993:621:35-49.
12. Korotzcr AR, Whittemore ER, Cot-man CW: Differential regulation by ß-amyloid peptides of intracellular free C'a* concentration in cultured rat microglia. Eur J Pharmacol 1995:288:125-130.
13. 2* homeostasis and cell death. J Neurosci 1995; 15:6239-6249.
14. Arispe N, Rojas E, Pollard HB: Alzheimer disease amyloid ß protein forms calcium channels in bilaycr membranes: Blockade by trome-thamine and aluminum. Proc Natl Acad Sei USA 1993:90:567-571.
15. Ying W: A new hypothesis of neu-rodegencrative diseases: The deleterious network hypothesis. Med Hypothesis 1996:47:307-313.
16. Voltcrra A, Trotti D, Tromba C, Floridi S, Racagni G: Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J Ncu-rosci 1994:14:2924-2932.
17. 2*-ATPase by activated oxygen through thiol- and lipid-dcpcndcnt mechanisms. Biochim Biophys Acta 1986:862:8-16.
18. Dyrks T, Dyrks E, Hartmann T, Masters C, Beyrcuthcr K: Amyloi-dogenicity of ßA and ßA-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J Biol Chem 1992:267:18210-18217.
19. Yan SD, Yan SF, Chen X, Fu J, Chen M, Kuppusamy P, Smith MA, Perry G, Godman GC, Nawroth P, Zweier JL, Stem D: Non-cnzymati-callv glycated tau in Alzheimer’s disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid ß-pep-tide. Nature Med 1995;1:693-699.
20. Frederikse PH, Garland D, Zigler JS Jr, Piatigorsky J: Oxidative stress increases production of (5-amyloid precursor protein and ß-amyloid (A beta) in mammalian lenses, and A beta has toxic effects on lens epithelial cells. J Biol Chem 1996:271: 10169-10174.
21. Mecocci P, MacGarvcy U, Kaufman AE, Koontz D, Schoffncr JM, Wallace DC, Beal MF: Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 1993:34:609-616.
22. Todoki K, Okabe E, Kivose T, Seki-shita T, Ito H: Oxygen free radical-mediated selective endothelial dysfunction in isolated coronary artery. Am J Physiol 1992;262:H806-H812.
23. Gabuzda D, Busciglio J, Chen LB, Matsudaira P, Yankncr BA: Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol C’hem 1994:269:13623-13628.
24. Meier-Ruge W, Bertoni-Freddari C: The significance of glucose turnover in the brain in the pathogenetic mechanisms of Alzheimer’s disease. Rev Neurosci 1996:7:1-19.
25. Hasham MI, Naumann D, Kim SU, Cashman NR, Quamme GA, Krieger C: Intracellular calcium concentrations during metabolic inhibition in the motoneuron cell line NSC-19. Can J Physiol Pharmacol 1994:72: 728-737.
26. Cortopassi G, Wang E: Modelling the effects of age-related mtDNA mutation accumulation: Complex I deficiency, superoxide and cell death. Biochim Biophys Acta 1995: 1271:171-176.
27. Bandy B, Davison AJ: Mitochondrial mutations may increase oxidative stress: Implications for carcinogenesis and aging. J Free Radie Biol Med 1990;8:523-539.
28. 2* activated hydrogen peroxide production in syn-aptosomes. Biochim Biophys Acta 1993:1176:208-214.
29. Kontos HA, Wei EP, Ellis EF, Jenkins LW, Povlishock JT, Rowe GT, Hess ML: Appearance of superoxide anion radical in cerebral extracellular space during increased prostaglandin synthesis in cats. Circ Res 1985:57:142-151.
30. Kowaltowski AJ, Castilho RF, Ver-cesi AE: Ca;*-induccd mitochondrial membrane pcrmeabilization: Role of coenzyme Q redox state. Am J Physiol 1995;269:C 141 -C147.
31. 2-scnsitivc enzymes from rat liver and within intact rat liver mitochondria. Biochcm J 1985:231:581-595.
32. Lizasoain I, Moro MA, Knowles RG, Darley-Usmar V, Moncada S: Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which arc differentially blocked by glutathione or glucose. Biochem J 1996:314:877-880.
33. Querfurth HW, Sclkoe DJ: Calcium ionophorc increases amyloid ß peptide production by cultured cells. Biochemistry 1994:33:4550-4561.
34. Braak H, Braak E: Evolution of the neuropathology of Alzheimer’s disease. Acta Neurol Scand 1996: 165(suppl):3-12.
35. 2*. J Ncurosci 1996:16:5795-5811.
36. Hsiao K, Chapman P, Nilscn S, Eck-man C, Harigava Y, Younkin S, Yang F, Cole G: Correlative memory deficits, Aß elevation, and amyloid plaques in transgenic mice. Science 1996:274:99-102.
37. Busciglio J, Lorenzo A, Yeh J, Yankner BA: p-Amyloid fibrils induce tau phosphorylat ion and loss of microtubule binding. Neuror. 1995: 14:879-888.
38. Pike CJ, Cummings BJ, Cotman CW: p-Amyloid induces neuritic dystrophy in vitro: Similarities with Alzheimer pathology. Neurorcport 1992:3:769-772.
39. Gittcr BD, Cox LM, Rydel RE, May PC: Amyloid p peptide potentiates cytokine secretion by interleukin-lP-activatcd human astrocytoma cells. Proc Natl Acad Sci USA 1995: 92:10738-10741.
40. Maurice T, Lockhart BP, Privat A: Amnesia induced in mice by centrally administered p-amyloid peptides involves cholinergic dysfunction. Brain Res 1996;706:181-193.
41. Yamatsuji T, Matsui T, Okamoto T, Komatsuzaki K, Takeda S, Fuku-moto H, Iwatsubo T, Suzuki N, As-ami-Odaka A, Ireland S, Kinanc B, Giambarclla U, Nishimolo I: G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer’s disease-associated mutants of APP. Science 1996:272:1349-1352.
42. Scheuncr D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad E, Viitanen M, Peskind E, Poorkaj P, Schcllen-bcrg G, Tanzi R, Wasco W, Lannfclt L, Selkoe D, Younkin S: Secreted amyloid p-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nature Med 1996:2:864-870.
43. Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkon-iemi A, Ninisto L, Haloncn P, Kon-tula K: Apolipoprotein E. dementia, and cortical deposition of p-amyloid protein. N Engl J Med 1995:333: 1242-1247.
44. 2*. J Neurol Neu-rosurg Psychiatry 1994:57:419-425.
45. Hensley K, Hall N, Subramaniam R, Cole P, Harris M, Aksenov M, Aksenova M, Gabbita SP, Wu JF, Carney JM, Lovell M, Markesbery WR, Butterfield DA: Brain regional correspondence between Alzheimer’s disease histopathology and biomarkers of protein oxidation. J Neurochem 1995:65:2146-2156.
46. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N: Oxidative damage in Alzheimer’s. Nature 1996:382:120-121.
47. Harman D: Free radical theory of aging: A hypothesis on pathogenesis of senile dementia of the Alzheimer's type. Age 1993:16:23-30.
48. Eisen A, Caine DB: Amyotrophic lateral sclerosis, Parkinson’s disease and Alzheimer's disease: Phylogenetic disorders of the human neocortex sharing many characteristics. Can J Neurol Sei 1992; 19(suppl): 117-120.
49. Schwab C, Steele JC, Akiyama H, McGeer EG, McGeer PL: Relationship of amyloid p/A4 protein to the neurofibrillary tangles in Guamanian parkinsonism-dementia. Acta Neuropathol 1995:90:287-298.
50. Ben-Shachar D, Youdim MB: In-tranigral iron injection induces behavioral and biochemical’parkinsonism' in rats. J Neurochem 1991: 57:2133-2135.
51. Sohal RS, Svcnsson I, Sohal BH, Brunk UT: Superoxide anion radical production in different animal species. Mech Age Dev 1989:49: 129-135.
52. Sohal RS, Agarwal S, Dubey A, Orr WC: Protein oxidative damage is associated with life expectancy of houseflies. Proc Natl Acad Sci USA 1993:90:7255-7259.
53. Ying W: Deleterious network of aging. Med Hypotheses, in press.
54. Grecnlund LJ, Deckwerth TL, Johnson EM Jr: Superoxide dismulasc delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death. Neuron 1995: 14:303-315.
55. Pacifici RE, Davies KJA: Protein, lipid and DNA repair systems in oxidative stress: The frcc-radical theory of aging revisited. Gerontology 1991;37:166-180.
56. Busciglio J, Yankncr BA: Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 1995:378: 776-779.
57. Ellis WG, McCulloch JR, Corley CL: Presenilc dementia in Down’s syndrome. Neurology 1974;24:101-06.
58. Troncoso JC, Costello A, Watson AL Jr, Johnson GV: In vitro polymerization of oxidized tau into filaments. Brain Res 1993:613:313-315.
59. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR: Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sei USA 1991;88:10540-10543.
60. Schwecrs O, Mandelkow E-M, Bier-nat J, Mandelkow E: Oxidation of cysteine-322 in the repeat domain of microtubule-associatcd protein tau controls the in vitro assembly of paired helical filaments. Proc Natl Acad Sei USA 1995:92:8463-8467.
61. Mccocci P, Cherubini A, Beal MF, Cccchetti R, Chionne F, Polidori MC, Romano G, Senin U: Altered mitochondrial membrane fluidity in AD brain. Neurosci Lett 1996:207: 129-132.
62. Forster MJ, Dubey A, Dawson KM, Stutts WA, Lai H, Sohal RS: Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc Natl Acad Sei USA 1996:93:4765-4769.
63. Montine TJ, Huang DY, Valentine WM, Amamath V, Saunders A, Wcisgraber KH, Graham DG, Strittmattcr WJ: Crosslinking of apolipoprotein E by products of lipid peroxidation. J Ncuropathol Exp Neurol 1996:55:202-210.
64. Kontos HA, Wei EP: Superoxide production in experimental brain injury. J Neurosurg 1986:64:803-807.
65. Davis RE, Miller S, Herrnstadt C, Ghosh S, Fahy E, Galasko D, Thai LJ, Parker WD: Specific point mutations in mitochondrial cytochrome oxidase genes are associated with sporadic Alzheimer’s disease. Neurology I996:46:A276.
66. van Rensburg SJ, Carstens ME, Po-tocnik FC, Aucamp AK, Taljaard JJ: Increased frequency of the transferrin C2 subtype in Alzheimer’s disease. Neuroreport 1993:4:1269-1271.
67. Hutchin T, Cortopassi G: A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc Natl Acad Sei USA 1995;92:6892-6895.
68. van Rensburg SJ, Carstens ME, Po-tocnik FCV, van der Spuy, van der Walt BJ, Taljaard JJF: Transferrin C2 and Alzheimer’s disease: Another piece of the puzzle found? Med Hypotheses 1995:44:268-272.
69. Parker WD Jr, Parks J, Filley CM, Kleinschmidt-DcMastcrs BK: Electron transport chain defects in Alzheimer’s disease brain. Neurology 1994:44:1090-1096.
70. Mcier-Ruge W, Bcrtoni-Freddari C, Iwangoff P: Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer’s disease. Gerontology 1994:40:246-252.
71. Hoycr S: Abnormalities of glucose metabolism in Alzheimer’s disease. Ann NY Acad Sei 1991;640:65-71.
72. Slansky I, Herholz K, Pietrzyk U, Kessler J, Grond M, Mielke R, Heiss W-D: Cognitive impairment in Alzheimer’s disease correlates w ith ventricular width and atrophy-corrected cortical glucose metabolism. Neuroradiology 1995:37:270-277.
73. Brouillct E, Hanraye P, Ferrante RJ, Dolan R, Leroy-Willig A, Kowall NW, Beal MF: Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc Natl Acad Sei USA 1995;92:7105-7109.
74. Beal MF: Docs impairment of energy metabolism result in excitotoxic neuronal death in neurodegenera-tivc illnesses? Ann Neurol 1992:31: 119-130.
75. Cheng B, Mattson MP: Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: Prevention by NGF and bFGF. Exp Neurol 1992; 117:114-123.
76. Gibbson GE, Peterson C: Aging decreases oxidative metabolism and the release and synthesis of acetylcholine. J Neurochem 1984:37:978-984.
77. crk converts TAU into a PHF-likc form as found in Alzheimer’s disease. Bio-chem Biophys Res Commun 1993; 193:639-647.
78. Roder HM, Ingram VM: Two novel kinases phosphorylate tau and the KSP site of heavy neurofilaments subunits in high stochiomctric ratios. J Neurosci 1991:11:3325-3343.
79. Hoycr S: Age-related changes in cerebral oxidative metabolism. Drugs Aging 1995:6:210-218.
80. Wei EP, Dietrich WD, Povlishock JT, Navari RM, Kontos HA: Functional, morphological, and metabolic abnormalities of the cerebral microcirculation after concussive brain injury in cats. Circ Res 1980:46:37-47.
81. Reiman EM, Casein RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D: Preclin-ical evidence of Alzheimer’s disease in persons homozygous for the e4 allele for apolipoprotein E. N Engl J Med 1996:334:752-758.
82. Davignon J, Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
83. 2+-binding proteins in human neurodegenerative disorders. Trends Neurosci 1992:15:259-264.
84. Mattson MP: Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and calcium influx in cultured hippocampal neurons. Neuron 1990:4: 105-117.
85. Llinas R, Sugimori M, Chcrksey BD, Smith RG, Delbono O, Stefani E, Appel S: IgG from amyotrophic lateral sclerosis patients increases current through P-type calcium channels in mammalian cerebellar Purkinjc cells and in isolated channel protein in lipid bilayer. Proc Natl Acad Sci USA 1993:90:11743-11747.
86. Khachaturian ZS: Calcium hypothesis of Alzheimer's disease and brain aging. Ann NY Acad Sci 1994:747: 1-11.
87. Vito P, Lacana E, D'Adamio L: Interfering with apoptosis: Ca*-bind-ing protein ALG-2 and Alzheimer's disease gene ALG-3. Science 1996: 271:521-525.
88. Trump BF, Berczesky IK: Calcium-mediated cell injury and cell death. FASEBJ 1995:9:219-228.
89. Goodman Y, Brucc AJ, Cheng B, Mattson MP: Estrogen attenuates and corticosterone exacerbates exci-totoxicity, oxidative injury, and amyloid bcta-peptidc toxicity in hippocampal neurons. J Neurochcm 1996;66:1836-1844.
90. Tang M-X, Jacobs D, Stem Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R: Effect of oestrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet 1996;348:429-432.
91. Mattson MP, Lovell MA, Ehmann WD, Markesbery WR: Comparison of the effects of elevated intracellular aluminum and calcium levels on the neuronal survival and tau im-munorreactivity. Brain Res 1993; 602:21-31.
92. Saito K-I, Elce JS, Hamos JE, Nixon RA: Widerspread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: A potential molecular basis for neuronal degeneration. Proc Natl Acad Sci USA 1993:90:2628-2632.
93. Shimohama S, Narita M, Matsushima H, Kirnura J, Kameyama M, Hagiwara M, Hidaka H, Taniguchi T: Assessment of protein kinase C isozymes by two-site enzyme immunoassay in human brains and changes in Alzheimer's disease. Neurology' 1993;43:1407-1413.
94. Blanco P, Huidobro A, Villalba M, Gomcz-Puertas P, Bogonez E, Perea R, Martinez-Serrano A, Aparicio JJ, Satrustcgui J: The activity of synaptosomal calcium channels is inversely correlated with working memory performance in memory impaired, aged rats. Neurosci Lett 1994; 165: 5-8.
95. Thibault O, Landfield PW: Increase in single L-type calcium channels in hippocampal neurons during aging. Science 1996;272:1017-1020.
96. 45Ca accumulation in rat brain after closed head injury; attenuation by the novel neuroprotective agent HU-211. Brain Res 1995:685:1 -11.
97. Spencer PS, Nunn PB, Hugon J, Lu-dolph AC, Ross SM, Roy DN, Robertson RC: Guam amyotrophic lateral sclerosis-parkinsonism-demcn-tia linked to a plant excitant neurotoxin. Science 1987:237:517-520.
98. Mayeux R, Ottman R, Macstre G, Ngai C, Tang M-X, Ginsberg H, Chun M, Tycko B, Shelanski M: Synergistic effects of traumatic head injury and apolipoprotein-cpsilon4 in patients with Alzheimer's disease. Neurology 1995;45:555-557.
99. Ohkura T, Isse K, Akazawa K, Ha-mamoto M, Yaoi Y, Hagino N: Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr J 1994;41: 361-371.